Vitamin D Level: is It Related to Disease Activity in Inflammatory Joint Disease?

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2009 Dec 25

PMID 20033415

Citations 25

Authors

Yolanda Braun-Moscovici

K Toledano

D Markovits

A Rozin

A M Nahir

A Balbir-Gurman

Affiliations

Soon will be listed here.

Abstract

The objectives of this study are to assess the vitamin D status in patients (pts) with inflammatory joint diseases (IJD), and its correlation with disease activity. 121 consecutive pts (85 rheumatoid arthritis (RA), 22 psoriatic arthritis (PSA), 14 ankylosing spondylitis (AS)) underwent clinical and laboratory evaluation which included kidney and liver function tests, serum calcium and phosphor levels, 25(OH)D and parathyroid hormone (PTH). Disease activity was assessed by DAS 28 in RA and PSA pts and by BASDAI in AS pts, sedimentation rate (ESR) and CRP. According to activity indexes, pts were divided into subgroups with low (DAS28 < 3.2 and BASDAI < 4), and moderate-to-high disease activity (DAS28 > 3.2 and BASDAI > 4). Associations between serum levels of 25(OH)D and age, gender, ethnicity, type and disease duration, treatment, (anti-tumor necrosis factorα (TNFα) agents or DMARDs), seasonal variations, and disease activity were assessed. Vitamin D deficiency was found in 51 pts (42.1%). The incidence was higher among Arab pts (76.7%) compared to Jews (23%). The difference of 25(OH)D levels between Arabs (mean 9.4 ± 4.2 ng/ml) and Jews (mean 17.8 ± 8.4 ng/ml) was statistically significant (p < 0.0001). We did not find correlation between vitamin D levels and the other evaluated factors. A surprisingly high incidence of vitamin D deficiency was found in IJD patients in a sunny Mediterranean country. This finding justifies the inclusion of vitamin D in the routine lab work-up of pts with IJD. The only statistical significant correlation was found between vitamin D level and ethnic origin. Further studies are needed to look for genetic polymorphism of vitamin D receptors.

Citing Articles

Environmental pollution impact on the severity of some rheumatic diseases: a comparative analytical study on inflammatory and non-inflammatory samples.

Elbeialy A, Sawy S, Elzomor H, Haddad R BMC Rheumatol. 2024; 8(1):50.

PMID: 39380067 PMC: 11460183. DOI: 10.1186/s41927-024-00420-8.

Is vitamin D associated with disease activity in patients with axial or peripheral spondyloarthritis? A real-life study.

Mbuyi M, Kavangh H, Grubisic F, Doko Vajdic I, Grazio S Rheumatol Int. 2024; 44(10):2079-2087.

PMID: 39180527 DOI: 10.1007/s00296-024-05674-6.

Vitamin D deficiency: concern for rheumatoid arthritis and COVID-19?.

Verma S, Chaturvedi V, Ganguly N, Mittal S Mol Cell Biochem. 2021; 476(12):4351-4362.

PMID: 34453644 PMC: 8401347. DOI: 10.1007/s11010-021-04245-8.

Additive Effects of VDBP and 1,25(OH)2D3 on the Viability and Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts.

Zhang Y, Li S, Zhuo F, Wang H, Geng X, Xu B Front Endocrinol (Lausanne). 2021; 11:583229.

PMID: 33584536 PMC: 7876401. DOI: 10.3389/fendo.2020.583229.

Vitamin D Deficiency and Rheumatoid Arthritis: Epidemiological, Immunological, Clinical and Therapeutic Aspects.

Heidari B, Hajian-Tilaki K, Babaei M Mediterr J Rheumatol. 2020; 30(2):94-102.

PMID: 32185348 PMC: 7045965. DOI: 10.31138/mjr.30.2.94.

References

Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D . Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007; 56(7):2143-9. DOI: 10.1002/art.22722. View

Lemire J, Archer D, Beck L, Spiegelberg H . Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr. 1995; 125(6 Suppl):1704S-1708S. DOI: 10.1093/jn/125.suppl_6.1704S. View

Bouillon R, Bischoff-Ferrari H, Willett W . Vitamin D and health: perspectives from mice and man. J Bone Miner Res. 2008; 23(7):974-9. DOI: 10.1359/jbmr.080420. View

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

Jahnsen J, Falch J, Mowinckel P, Aadland E . Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002; 37(2):192-9. DOI: 10.1080/003655202753416876. View

Hayes C, Nashold F, Spach K, Pedersen L . The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003; 49(2):277-300. View

Dawodu A, Absood G, Patel M, Agarwal M, Ezimokhai M, Abdulrazzaq Y . Biosocial factors affecting vitamin D status of women of childbearing age in the United Arab Emirates. J Biosoc Sci. 1998; 30(4):431-7. DOI: 10.1017/s0021932098004313. View

Garrett S, Jenkinson T, Kennedy L, Whitelock H, Gaisford P, Calin A . A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21(12):2286-91. View

Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt K . Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int. 2005; 16(12):1999-2004. DOI: 10.1007/s00198-005-1990-5. View

10.

Nielen M, van Schaardenburg D, Lems W, van de Stadt R, de Koning M, Reesink H . Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthritis Rheum. 2006; 54(11):3719-20. DOI: 10.1002/art.22191. View

11.

Kristal-Boneh E, Froom P, Harari G, Ribak J . Seasonal changes in calcitropic hormones in Israeli men. Eur J Epidemiol. 1999; 15(3):237-44. DOI: 10.1023/a:1007528428702. View

12.

Garcia-Lozano J, Gonzalez-Escribano M, Valenzuela A, Garcia A, Nunez-Roldan A . Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet. 2001; 28(1):89-93. DOI: 10.1046/j.1365-2370.2001.00233.x. View

13.

Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi M . Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol. 2007; 24(6):702-4. View

14.

Arnson Y, Amital H, Shoenfeld Y . Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007; 66(9):1137-42. PMC: 1955167. DOI: 10.1136/ard.2007.069831. View

15.

Gaugris S, Heaney R, Boonen S, Kurth H, Bentkover J, Sen S . Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005; 98(9):667-76. DOI: 10.1093/qjmed/hci096. View

16.

Muller K, Diamant M, Bendtzen K . Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. Immunol Lett. 1991; 28(2):115-20. DOI: 10.1016/0165-2478(91)90108-m. View

17.

Holick M . High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81(3):353-73. DOI: 10.4065/81.3.353. View

18.

Mukamel M, Weisman Y, Somech R, EISENBERG Z, Landman J, Shapira I . Vitamin D deficiency and insufficiency in Orthodox and non-Orthodox Jewish mothers in Israel. Isr Med Assoc J. 2001; 3(6):419-21. View

19.

Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G . Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int. 1998; 62(3):193-8. DOI: 10.1007/s002239900416. View

20.

Lowenthal M, Shany S . Osteomalacia in Bedouin women of the Negev. Isr J Med Sci. 1994; 30(7):520-3. View